GHASSAN ZALZALEH, MD
Hematology & Oncology Physician · OAK LAWN, IL
Individual Active NPI 1992704035
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 679 | 192,003 | $16,105,919 | $4,801,256 | $3,814,822 |
| 2023 | 711 | 277,073 | $22,304,545 | $6,104,800 | $4,847,507 |
| 2022 | 787 | 316,841 | $21,616,166 | $5,958,786 | $4,738,279 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J1439 | Injection, ferric carboxymaltose, 1 mg | 27,750 | $1 | $1 |
| J9271 | Injection, pembrolizumab, 1 mg | 27,600 | $56 | $45 |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 21,780 | $3 | $2 |
| J9299 | Injection, nivolumab, 1 mg | 9,260 | $31 | $25 |
| J9267 | Injection, paclitaxel, 1 mg | 6,205 | $0 | $0 |
| J1449 | Injection, eflapegrastim-xnst, 0.1 mg | 5,148 | $27 | $21 |
| J1453 | Injection, fosaprepitant, 1 mg | 4,500 | $0 | $0 |
| J0897 | Injection, denosumab, 1 mg | 4,500 | $26 | $21 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 2,290 | $0 | $0 |
| J9041 | Injection, bortezomib, 0.1 mg | 1,854 | $2 | $1 |
| J0461 | Injection, atropine sulfate, 0.01 mg | 1,320 | $0 | $0 |
| J9312 | Injection, rituximab, 10 mg | 1,140 | $77 | $61 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Hematology & Oncology Physician | 207RH0003X | ✓ | 036089713 | IL |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Hematology & Oncology Physician providers in Illinois
- NPI 1598765166
- NPI 1497964753
- NPI 1124587365
- NPI 1902364938
- NPI 1356439178
- NPI 1043242860
- NPI 1982053013
- NPI 1073539680
See all Hematology & Oncology Physician providers in Illinois →
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.